CCL2 and neoplasm: The aim of our study was to analyze for the first time the expression of CCL2 in BCa tumor cells and immune cells by immunohistochemistry and to correlate the results with clinicopathological and survival data to assess the impact of CCL2 as a prognostic factor in BCa.